{"id":8484,"date":"2025-10-21T14:08:22","date_gmt":"2025-10-21T06:08:22","guid":{"rendered":"https:\/\/www.huasan.net\/?p=8484"},"modified":"2025-10-21T14:08:24","modified_gmt":"2025-10-21T06:08:24","slug":"safety-and-feasibility-of-4-1bb-co-stimulated-cd19-specific-car-nk-cell-therapy-in-refractory-relapsed-large-b-cell-lymphoma%ef%bc%9aa-phase-1-trial","status":"publish","type":"post","link":"https:\/\/www.huasan.net\/?p=8484","title":{"rendered":"Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory-relapsed large B cell lymphoma\uff1aa phase 1 trial"},"content":{"rendered":"\n<div data-wp-interactive=\"core\/file\" class=\"wp-block-file\"><object data-wp-bind--hidden=\"!state.hasPdfPreview\" hidden class=\"wp-block-file__embed\" data=\"https:\/\/www.huasan.net\/wp-content\/uploads\/2025\/10\/Safety-and-feasibility-of-4-1BB-co-stimulated-CD19-specific-CAR-NK-cell-therapy-in-refractory-relapsed-large-B-cell-lymphoma\uff1aa-phase-1-trial.pdf\" type=\"application\/pdf\" style=\"width:100%;height:600px\" aria-label=\"\u5d4c\u5165 Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory-relapsed large B cell lymphoma\uff1aa phase 1 trial\"><\/object><a id=\"wp-block-file--media-4e8ba89d-30a4-459d-8daa-be9322327bd7\" href=\"https:\/\/www.huasan.net\/wp-content\/uploads\/2025\/10\/Safety-and-feasibility-of-4-1BB-co-stimulated-CD19-specific-CAR-NK-cell-therapy-in-refractory-relapsed-large-B-cell-lymphoma\uff1aa-phase-1-trial.pdf\">Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory-relapsed large B cell lymphoma\uff1aa phase 1 trial<\/a><a href=\"https:\/\/www.huasan.net\/wp-content\/uploads\/2025\/10\/Safety-and-feasibility-of-4-1BB-co-stimulated-CD19-specific-CAR-NK-cell-therapy-in-refractory-relapsed-large-B-cell-lymphoma\uff1aa-phase-1-trial.pdf\" class=\"wp-block-file__button wp-element-button\" download aria-describedby=\"wp-block-file--media-4e8ba89d-30a4-459d-8daa-be9322327bd7\">\u4e0b\u8f7d<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15,64,14,22,97],"tags":[],"class_list":["post-8484","post","type-post","status-publish","format-standard","hentry","category-nk","category-64","category-14","category-22","category-97"],"_links":{"self":[{"href":"https:\/\/www.huasan.net\/index.php?rest_route=\/wp\/v2\/posts\/8484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.huasan.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.huasan.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.huasan.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.huasan.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8484"}],"version-history":[{"count":1,"href":"https:\/\/www.huasan.net\/index.php?rest_route=\/wp\/v2\/posts\/8484\/revisions"}],"predecessor-version":[{"id":8486,"href":"https:\/\/www.huasan.net\/index.php?rest_route=\/wp\/v2\/posts\/8484\/revisions\/8486"}],"wp:attachment":[{"href":"https:\/\/www.huasan.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.huasan.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.huasan.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}